Insulet Corp. (PODD)
296.19
-8.30
(-2.73%)
USD |
NASDAQ |
Dec 08, 16:00
298.50
+2.31
(+0.78%)
Pre-Market: 08:03
Insulet EPS Diluted (Quarterly): 1.240 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Boston Scientific Corp. | 0.5048 |
| ResMed, Inc. | 2.373 |
| Baxter International, Inc. | 0.0175 |
| Tandem Diabetes Care, Inc. | -0.3128 |
| Masimo Corp. | -1.859 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 87.60M |
| Revenue (Quarterly) | 706.30M |
| Total Expenses (Quarterly) | 618.70M |
| Enterprise Value | 21.11B |
| Gross Profit Margin (Quarterly) | 72.70% |
| Profit Margin (Quarterly) | 12.40% |
| Earnings Yield | 1.16% |
| Operating Earnings Yield | 2.04% |
| Normalized Earnings Yield | 1.562 |